Earnings Releases·Nov 5, 2026, 7:01 AM ET

WW International — Third Quarter 2026 Earnings Summary

Q3 2026 revenue declined 11% year-over-year to $152.9 million, driven by a 21.5% drop in Behavioral Subscription Revenue, though Clinical Subscription Revenue surged 48% to $38.0 million (25% of total).
Net income reversed from a $57.5 million loss in Q3 2025 to a $15.1 million profit in Q3 2026, while Adjusted EBITDA rose 21% year-over-year to $51.7 million with a 33.8% margin.
The company narrowed full-year fiscal 2026 revenue guidance to $625–$630 million and Adjusted EBITDA guidance to $110–$115 million, reflecting improved visibility post-bankruptcy reorganization.
Strategic focus on higher-value offerings yielded 40% year-over-year growth in Clinical subscribers and 16% growth in Core+ subscribers, with total end-of-period subscribers reaching 2.3 million.
Balance sheet strength improved with cash and equivalents rising to $126.4 million and long-term debt decreasing to $423.97 million, alongside a $4.6 million gain on debt extinguishment.